Zabala, Avelina C.
HRN: 25-81-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2024
CEFTRIAXONE 1G (VIAL)
09/03/2024
09/10/2024
IV
2g
Q24
Pneumonia
Waiting Final Action